Skip to main navigation Skip to search Skip to main content

Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections

  • Olimpia Lamberti
  • , Dingase Kumwenda
  • , Helen Kelly
  • , Paul Kamfwa
  • , Sekeleghe A. Kayuni
  • , J. Russell Stothard
  • , Amaya L. Bustinduy
  • London School of Hygiene and Tropical Medicine
  • Kamuzu University of Health Sciences
  • Queen Elizabeth Central Hospital Malawi
  • University College Dublin
  • Zambian Ministry of Health
  • Liverpool School of Tropical Medicine

Research output: Contribution to journalArticlepeer-review

Abstract

In sub-Saharan Africa, adult women and adolescent girls face a high burden of genital tract co-infections, either by sexual or non-sexual transmission route. Distinguishing between these modes of transmission has important implications for diagnosis and treatment and is particularly relevant for community perceptions and associated stigma. Causative pathogens and parasites include a wide spectrum of organisms, including bacteria, viruses, fungi, protozoans, and helminths. Understanding shared risk factors, overlapping geographical distribution, and potential biological interactions between these infections is paramount for an integrated approach to prevention, management, and control of genital co-infections in African women. This Series paper assesses one of the most neglected and least understood genital infections, female genital schistosomiasis (FGS), mainly caused by the waterborne parasitic helminth Schistosoma haematobium . We explore current evidence on its interactions with other genital infections, including those acquired by sexual transmission (HIV and human papillomavirus) and non-sexual transmission (bacterial vaginosis and vulvovaginal candidiasis). We highlight the emerging role of zoonotic and hybrid Schistosoma species in FGS and consider their potential clinical implications. Opportunities to integrate FGS into broader sexual and reproductive health frameworks are explored within shared diagnostic tools and combined treatment strategies, with the ultimate goal of improving clinical care for affected women.

Original languageEnglish
Article number101425
JournalThe Lancet Microbe
Volume7
Issue number6
DOIs
Publication statusPublished - 11 Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections'. Together they form a unique fingerprint.

Cite this